Group 1 - The company reported total revenue of HKD 94.7 million for the six months ending June 30, 2025, representing a year-on-year decrease of 28.5% [1] - The decline in revenue is primarily attributed to weak performance in the healthcare segment, along with reduced interest income from financial investments, partially offset by stable contributions from property investments [1] - The underlying recurring profit, calculated by excluding unrealized fair value changes of financial assets and investment properties, decreased by 26.6% to HKD 45.3 million, mainly due to reduced sales contributions from the healthcare segment [1] Group 2 - The company declared an interim dividend of HKD 0.03 per share and a special interim dividend of HKD 0.05 per share [1]
白花油(00239.HK)中期总收入9470万港元 同比减少28.5%